TherapeuticsMD Inc (TXMD) — Capital Reinvestment Ratio

Latest as of March 2024: 712.82x

TherapeuticsMD Inc (TXMD) has a Capital Reinvestment Ratio of 712.82x as of March 2024, meaning it reinvests 713% of its operating cash flow ($11.00K) in capital expenditures ($7.84 Million). See TherapeuticsMD Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

712.82x
Capex / Operating Cash Flow

Operating Cash Flow

$11.00K
USD

Capital Expenditures

$7.84 Million
USD

Data as of

Mar 2024
Most recent filing

TherapeuticsMD Inc Capital Reinvestment Ratio (1993–2006)

This chart tracks TherapeuticsMD Inc's Capital Reinvestment Ratio across 11 annual periods. Check TXMD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for TherapeuticsMD Inc (1993–2006)

Year-by-year Capital Reinvestment Ratio for TherapeuticsMD Inc from 1993 to 2006. For live market cap and broader valuation context, see market value of TherapeuticsMD Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2006 0.18x $329.84K $57.75K ▼ -21.7%
2005 0.22x $412.34K $92.23K ▼ -85.1%
2004 1.50x $207.73K $311.05K ▼ -15.4%
2003 1.77x $140.00K $247.71K ▲ +182.6%
2002 0.63x $100.08K $62.66K ▲ +367.2%
2001 0.13x $161.95K $21.70K ▼ -97.2%
1998 4.74x $44.60K $211.37K ▲ +285.1%
1997 1.23x $77.53K $95.40K ▲ +639.6%
1995 0.17x $63.45K $10.56K ▼ -82.8%
1994 0.97x $72.86K $70.35K ▼ -35.9%
1993 1.51x $59.76K $90.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow